Antivascular endothelial growth factor in hereditary dystrophies

Research output: Chapter in Book/Report/Conference proceedingChapter


Choroidal neovascularization can rarely complicate the course of a number of chorioretinal hereditary dystrophies leading to an even further impaired vision function. In recent years, several case reports and case series have shown that intravitreal injections of antivascular endothelial growth factor drugs can be effective in treating subfoveal choroidal neovascularization secondary to chorioretinal dystrophies either improving vision, or at least halting its progressive loss. Additional studies are warranted to confirm the initial positive response and to assess the best therapeutic regimen.

Original languageEnglish
Title of host publicationAnti-VEGF
PublisherS. Karger AG
Number of pages4
ISBN (Print)9783805595308, 9783805595292
Publication statusPublished - Aug 13 2010

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Antivascular endothelial growth factor in hereditary dystrophies'. Together they form a unique fingerprint.

Cite this